DK0817625T3 - Sammensætninger til behandling af lysbeskadiget hud omfattende en RAR-alfa-antagonist og et multi-selektivt retinoid - Google Patents

Sammensætninger til behandling af lysbeskadiget hud omfattende en RAR-alfa-antagonist og et multi-selektivt retinoid

Info

Publication number
DK0817625T3
DK0817625T3 DK96908071T DK96908071T DK0817625T3 DK 0817625 T3 DK0817625 T3 DK 0817625T3 DK 96908071 T DK96908071 T DK 96908071T DK 96908071 T DK96908071 T DK 96908071T DK 0817625 T3 DK0817625 T3 DK 0817625T3
Authority
DK
Denmark
Prior art keywords
compositions
treatment
light
damaged skin
rar
Prior art date
Application number
DK96908071T
Other languages
English (en)
Inventor
Graeme Findlay Bryce
Stanley Seymour Shapiro
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0817625T3 publication Critical patent/DK0817625T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96908071T 1995-03-31 1996-03-19 Sammensætninger til behandling af lysbeskadiget hud omfattende en RAR-alfa-antagonist og et multi-selektivt retinoid DK0817625T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/414,242 US5807900A (en) 1995-03-31 1995-03-31 Method for identifying compounds having increased activity for the repair of skin photodamage
PCT/EP1996/001176 WO1996030009A2 (en) 1995-03-31 1996-03-19 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid

Publications (1)

Publication Number Publication Date
DK0817625T3 true DK0817625T3 (da) 2003-09-15

Family

ID=23640589

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96908071T DK0817625T3 (da) 1995-03-31 1996-03-19 Sammensætninger til behandling af lysbeskadiget hud omfattende en RAR-alfa-antagonist og et multi-selektivt retinoid

Country Status (9)

Country Link
US (1) US5807900A (da)
EP (1) EP0817625B1 (da)
AT (1) ATE240725T1 (da)
AU (1) AU5146096A (da)
DE (1) DE69628287T2 (da)
DK (1) DK0817625T3 (da)
ES (1) ES2201175T3 (da)
PT (1) PT817625E (da)
WO (1) WO1996030009A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753627B1 (fr) * 1996-09-20 2003-02-21 Galderma Rech Dermatologique Utilisation des inhibiteurs de l'activite de l'acide retinoique pour favoriser la cicatrisation
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
US6083973A (en) * 1998-03-09 2000-07-04 Syntex (U.S.A.) Inc. Methods for inhibiting mucin secretion using RAR α selective antagonists
JP2003524604A (ja) * 1998-10-14 2003-08-19 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Ｕｖによって誘発された機能的ビタミンａ欠乏症のレチノイドの局部塗布による防止方法
DE19926779A1 (de) * 1999-06-11 2000-12-14 Basf Ag Verwendung von substituierten Vinyl-tetrahydronaphthalinen und Vinyl-benzotetrahydropyranen als Lichtschutzmittel
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials
KR100582806B1 (ko) 2000-05-02 2006-05-23 에프. 호프만-라 로슈 아게 신규한 감마 선택적인 레티노이드
EP1935869A1 (en) 2000-10-02 2008-06-25 F. Hoffmann-La Roche Ag Retinoids for the treatment of emphysema
US20050202055A1 (en) * 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
EP2613776B1 (en) 2010-09-01 2020-07-29 Thomas Jefferson University Composition and method for muscle repair and regeneration
WO2012076842A1 (en) * 2010-12-09 2012-06-14 University Of Durham Synthetic retinoids for control of cell differentiation
US8772273B2 (en) 2011-10-04 2014-07-08 Quretino Therapeutics, Inc. Formulations and uses of retinoic acid receptor selective agonists
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
WO2014145295A1 (en) 2013-03-15 2014-09-18 Avisenna Cosmetics, Llc Topical compositions for reducing aging effects
JP2022550432A (ja) 2019-10-02 2022-12-01 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 大動脈弁の石灰化を後退、予防、又は遅延させるためのレチノイン酸受容体（ｒａｒ）アゴニストの使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
US4230701A (en) * 1979-03-21 1980-10-28 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
EP0357646B1 (en) * 1987-04-06 1995-03-22 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid
US5075333A (en) * 1987-08-19 1991-12-24 Hoffmann-La Roche Inc. Tetrahydronaphthalene and indane compounds useful for reversing the photo-damage in sun-exposed skin
WO1993003713A1 (en) * 1991-08-23 1993-03-04 The Salk Institute For Biological Studies Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
CZ282548B6 (cs) * 1992-01-22 1997-08-13 F. Hoffmann-La Roche Ag Farmaceutický přípravek
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids

Also Published As

Publication number Publication date
WO1996030009A3 (en) 1997-01-03
WO1996030009A2 (en) 1996-10-03
EP0817625B1 (en) 2003-05-21
DE69628287T2 (de) 2004-04-08
US5807900A (en) 1998-09-15
DE69628287D1 (de) 2003-06-26
ES2201175T3 (es) 2004-03-16
PT817625E (pt) 2003-10-31
AU5146096A (en) 1996-10-16
ATE240725T1 (de) 2003-06-15
EP0817625A2 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
DK0817625T3 (da) Sammensætninger til behandling af lysbeskadiget hud omfattende en RAR-alfa-antagonist og et multi-selektivt retinoid
FI963692A (fi) Menetelmiä ja koostumuksia, jotka ovat käyttökelpoisia angiogeneesin inhibointiin
BR9611137A (pt) Composições e métodos para distribuição bucal de agentes farmacêuticos
AR016399A1 (es) Composiciones farmaceuticas, composiciones farmaceuticas para uso con una segunda composicion para obtener una mejora en el efecto terapeutico, un kit quelas contiene y uso de un compuesto para preparar la composicion
DK1169060T3 (da) Natriumkanalblokkerpræparater og anvendelse deraf
DK0734729T3 (da) Anvendelse af en CGRP-antagonist til behandling af hudrødme af neurogen oprindelse og den opnåede sammensætning
TR200001982T2 (tr) Farmasötik vurulu salınımlı oral dozaj şekli.
DK0782445T3 (da) Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
ATE192731T1 (de) Retinoid trienverbindungen und verfahren
ES2162051T3 (es) Preparacion dermatologica para tratar queratosis actinicas.
MX9401294A (es) Derivados de azolona sustituida
AR004052A1 (es) Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico
DE69828043D1 (de) Fluoridfreie zahnremineralisierung
ITRM970254A0 (it) Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato
ES2181670T3 (es) Peptidos que conservan una actividad similar a la de la tromboespondina y su utilizacion terapeutica.
PT952975E (pt) Compostos bi-aromaticos ligados por um radical hetero-etinileno e composicoes farmaceuticas e cosmeticas que os contem
PT721467E (pt) Utilizacao de relaxina como analgesico e paliativo para dor refractaria
DK0981363T3 (da) Somatostatinagonister til reduktion af legemsvægt
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
DK0841933T3 (da) Præparater med Bowman-Birk-inhibitor til behandling af inflammatoriske sygdomme
IL125297A0 (en) Compositions including calcium influx blockers for inhibiting cell growth
ATE270113T1 (de) Zusammenstellungen zur verbesserten wundheilung
BR9713349A (pt) Método e dispositivo para adaptar uma estrutura de ponte para ajustar elementos de ancoragem em uma mandìbula de paciente.
ITMI910013A1 (it) Dispositivo di vincolo, per parti di viadotti e simili